How we can help battle COVID-19
How we can help battle COVID-19
As the spread of the Coronavirus (COVID-19) persists throughout the global community, we want you to know that we are actively engaged in facilitating access to our products that are essential for your patients.
Detects ECG changes suggestive of a heart attack.
READ MORE
Allows you to email an ECG report to anyone
READ MORE
We connect to most major EMR systems.
READ MORE

What we do?

VectraCor uses its patented technology to design and develop medical devices to simplify and reduce costs of diagnostic testing as well as improve patient care. Our latest technology, VectraplexECG can detect ECG changes suggestive of a heart attack and derive a 15-22 lead ECG utilizing only 5-electrodes. We have a entire suite of products that are durable, mobile, and ready to turn an off-the-shelf tablet or laptop into a medical device. Our products are FDA cleared, CE marked, and VectraCor is
ISO-13485 certified.

_________________________________________________________________________________________________________

750000

People in the U.S have heart attacks each year

116000

People die each year from a heart attack

550000

Have a heart attack for the first time each year

200000

Have recurrent heart attacks

Heart Disease Stroke and Research Statisitcs At-a-Glance by American Heart Association

OUR PRODUCTS

We have a range of products to get you started whether you are an urgent care, primary care, or hospital.

Complete the form to request a demo

Awards